シナール配合顆粒
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB00126 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 42 |
| 日本商品名（例） | シナール配合顆粒, シーピー配合顆粒 |
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | non-syndromic esophageal malformation | 99% | DL |
| 2 | esophageal disease | 99% | DL |
| 3 | congenital prothrombin deficiency | 99% | DL |
| 4 | injury | 99% | DL |
| 5 | biotin metabolic disease | 99% | DL |
| 6 | florid cemento-osseous dysplasia | 99% | DL |
| 7 | perinatal disease | 99% | DL |
| 8 | segmental odontomaxillary dysplasia | 99% | DL |
| 9 | disease by subcellular system affected | 99% | DL |
| 10 | vitamin deficiency disorder | 99% | DL |
| 11 | radiation or chemically induced disorder | 99% | DL |
| 12 | cell proliferation disorder | 99% | DL |
| 13 | iatrogenic disease | 99% | DL |
| 14 | regional odontodysplasia | 99% | DL |
| 15 | esophageal ulcer | 99% | DL |
| 16 | esotropia | 99% | DL |
| 17 | ascorbic acid deficiency | 98% | DL |
| 18 | glycerol metabolism disease | 98% | DL |
| 19 | hemorrhagic disease of newborn | 98% | DL |
| 20 | anemia of prematurity | 98% | DL |
| 21 | ochronosis disorder | 97% | DL |
| 22 | folic acid deficiency anemia | 97% | DL |
| 23 | Keshan disease | 94% | DL |
| 24 | steatitis | 94% | DL |
| 25 | potassium deficiency | 94% | DL |
| 26 | swayback | 94% | DL |
| 27 | choline deficiency disease | 94% | DL |
| 28 | bone fracture | 93% | DL |
| 29 | gonococcal urethritis | 92% | DL |
| 30 | Ureaplasma urethritis | 92% | DL |
| 31 | burn | 92% | DL |
| 32 | ariboflavinosis | 91% | DL |
| 33 | protein-energy malnutrition | 91% | DL |
| 34 | urinary tract infection (disease) | 91% | DL |
| 35 | magnesium deficiency | 91% | DL |
| 36 | inborn error of biotin metabolism | 91% | DL |
| 37 | spinal injury | 91% | DL |
| 38 | uterine inflammatory disease | 91% | DL |
| 39 | dyskinesia of esophagus | 90% | DL |
| 40 | nasal cavity disease | 90% | DL |
| 41 | ankle injury | 90% | DL |
| 42 | scurvy | 83% | DL |
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。